[{"AccountsPayableCurrent_0_Q2_USD":5945000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":10076000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":1969000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_0_Q2_shares":3314000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_0_Q2_USD":50.2,"AssetRetirementObligationsNoncurrent_0_Q2_USD":272000.0,"LiabilitiesFairValueDisclosure_0_Q2_USD":1628000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":4977000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":1036000.0,"InterestIncomeExpenseNonoperatingNet_2_Q2_USD":4026000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_2_Q2_USD":379000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":4977000.0,"AssetsFairValueDisclosure_0_Q2_USD":430320000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q2_USD":1428000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q2_USD":676000.0,"InterestIncomeExpenseNonoperatingNet_1_Q2_USD":1950000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q2_USD":360264000.0,"AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_0_Q2_USD":80099000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_2_Q2_USD":147000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-5631000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":7900000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_2_Q2_USD":462000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q2_USD":374000.0,"DeferredIncomeTaxesAndTaxCredits_2_Q2_USD":-1224000.0,"DeferredTaxAssetsLiabilitiesNetNoncurrent_0_Q2_USD":12418000.0,"WeightedAverageNumberDilutedSharesOutstandingAdjustment_2_Q2_shares":856000.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":7022000.0,"EarningsPerShareDiluted_1_Q2_USD":-0.3,"EarningsPerShareDiluted_2_Q2_USD":0.36,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_0_Q2_USD":47904000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q2_USD":374000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_2_Q2_USD":462000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_1_Q2_USD":119000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_0_Q2_USD":32699000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q2_USD":361016000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q2_USD":280917000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q2_USD":74946000.0,"OperatingLeasePayments_2_Q2_USD":1784000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":7837000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q2_pure":0.065,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_2_Q2_USD":1498000.0,"PaymentsToAcquireMarketableSecurities_2_Q2_USD":171884000.0,"ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_2_Q2_USD":163273000.0,"OperatingLeasePayments_1_Q2_USD":1048000.0,"RestrictedCashAndCashEquivalentsNoncurrent_0_Q2_USD":608000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":27619000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":80189000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_2_Q2_USD":1997000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_1_Q2_USD":866000.0,"UnrecognizedTaxBenefits_0_Q2_USD":764000.0,"UnrecognizedTaxBenefitsPeriodIncreaseDecrease_1_Q2_USD":539000.0,"RestrictedStockValueSharesIssuedNetOfTaxWithholdings_1_Q2_USD":-358000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":5330000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":3764000.0,"OperatingLeaseLiability_0_Q2_USD":9094000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":23108000.0,"IncreaseDecreaseInOtherNoncurrentLiabilities_2_Q2_USD":-964000.0,"LeaseCost_1_Q2_USD":1438000.0,"LeaseCost_2_Q2_USD":2580000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q2_USD":9949000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFive_0_Q2_USD":519000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q2_USD":608000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q2_USD":2787000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q2_USD":3927000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q2_USD":2108000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q2_USD":855000.0,"LettersOfCreditOutstandingAmount_0_Q2_USD":608000.0,"LiabilityForUncertainTaxPositionsNoncurrent_0_Q2_USD":764000.0,"OperatingLeaseCost_1_Q2_USD":950000.0,"OperatingLeaseCost_2_Q2_USD":1613000.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":314005000.0,"VariableLeaseCost_1_Q2_USD":488000.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":640000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":19836000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":-731000.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":-23694000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":4536000.0,"Liabilities_0_Q2_USD":27510000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":513501000.0,"LiabilitiesCurrent_0_Q2_USD":19516000.0,"IncomeTaxExpenseBenefit_1_Q2_USD":-3920000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":5524000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":27037000.0,"NetIncomeLoss_1_Q2_USD":-6005000.0,"NetIncomeLoss_2_Q2_USD":7438000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":842000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":19835000.0,"ProfitLoss_2_Q2_USD":7438000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-9453000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":9738000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":-2416000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q2_USD":-9925000.0,"AccountsReceivableNetCurrent_0_Q2_USD":27619000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":608000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q2_shares":3714000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":2457000.0,"Assets_0_Q2_USD":513501000.0,"AssetsCurrent_0_Q2_USD":402709000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_Q2_USD":5022000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":74338000.0,"CommonStockSharesOutstanding_0_Q2_shares":19986000.0,"CommonStockValue_0_Q2_USD":200000.0,"CostsAndExpenses_1_Q2_USD":39494000.0,"CostsAndExpenses_2_Q2_USD":79193000.0,"GeneralAndAdministrativeExpense_1_Q2_USD":6884000.0,"GeneralAndAdministrativeExpense_2_Q2_USD":13805000.0,"CommonStockSharesIssued_0_Q2_shares":19986000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":171178000.0,"StockholdersEquity_0_Q2_USD":485991000.0,"AccruedLiabilitiesCurrent_0_Q2_USD":9807000.0,"CapitalExpendituresIncurredButNotYetPaid_2_Q2_USD":109000.0,"EarningsPerShareBasic_2_Q2_USD":0.37,"EarningsPerShareBasic_1_Q2_USD":-0.3,"NonoperatingIncomeExpense_1_Q2_USD":1950000.0,"NonoperatingIncomeExpense_2_Q2_USD":4026000.0,"OtherAssetsNoncurrent_0_Q2_USD":92000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2_Q2_USD":61.8,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_0_Q2_USD":30213000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0_Q2_USD":40.39,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_2_Q2_shares":100000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_Q2_shares":684000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_Q2_USD":32699000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_2_Q2_USD":69.61,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":19922000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q2_shares":1978000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2_Q2_USD":29.68,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q2_USD":50.2,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q2_shares":3314000.0,"CommitmentsAndContingencies_0_Q2_USD":null,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.01,"CommonStockSharesAuthorized_0_Q2_shares":100000000.0,"DepreciationAndAmortization_2_Q2_USD":1819000.0,"OperatingIncomeLoss_1_Q2_USD":-11875000.0,"OperatingIncomeLoss_2_Q2_USD":996000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":32610000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":65388000.0,"ShareBasedCompensation_2_Q2_USD":10076000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_2_Q2_shares":237000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":4716000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":19922000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":20692000.0,"IncomeTaxesPaid_2_Q2_USD":50000.0,"AccruedProfessionalFeesCurrent_0_Q2_USD":499000.0,"IncreaseDecreaseInAccruedLiabilities_2_Q2_USD":-5585000.0,"VariableLeaseCost_2_Q2_USD":967000.0,"Ticker":"ENTA","CIK":"1177648","name":"ENANTA PHARMACEUTICALS INC","OfficialName":"Enanta Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20200331","fy":"2020.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1492537180.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: In Vitro & In Vivo Diagnostic Substances","Market":"NASDAQ","SP500":"nan","filed":"20200511"}]